Dendritic cells initiate a two-stage mechanism for T lymphocyte proliferation by unknown
DENDRITIC  CELLS  INITIATE  A  TWO-STAGE  MECHANISM  FOR 
T  LYMPHOCYTE  PROLIFERATION* 
Be JONATHAN  M.  AUSTYN,~ RALPH  M.  STEINMAN,§ DAVID  E.  WEINSTEIN, 
ANGELA GRANELLI-PIPERNO, AND MICHAEL A.  PALLADINO 
From the Rockefeller University, New York 10021; and the Memorial Sloan-Kettering Cancer Center, 
New York 10021 
Previous studies of dendritic cells (DC)1 (reviewed in 1-3) have revealed the potent 
immunostimulatory capacities of this class of leukocyte. However, relatively little is 
known of their mechanism of action. We have used a  polyclonal lymphocyte mito- 
genesis system  to  examine this  question.  Klinkert et  al.  (4)  and  Phillips et  al.  (5) 
showed that T  cells, modified with sodium periodate, proliferate quickly and exten- 
sively in  the  presence of DC.  This  assay  has  been used  to  identify two  stages  in 
oxidative mitogenesis. In the first stage, viable DC induce both the release of T  cell 
growth factor, or interleukm 2  (IL-2)  (reviewed in 6-8), and T  lymphocyte respon- 
siveness to  IL-2.  In the  second stage,  which  can occur in the  absence of DC,  IL-2 
alone mediates proliferation of these responsive T  cells. 
Materials and Methods 
Animals.  Mice were of either sex and 4-14 wk old. Swiss mice were from Taconic Farms, 
Germantown, NY, and the Laboratory Animal Research Center of The Rockefeller University; 
C3H/HeJ were from The Jackson Laboratory, Bar Harbor, ME; all other inbred strains were 
from The Trudeau Institute, Saranac Lake, NY. 
Antibodies.  33D1  (9)  and B21-2  (10) are rat monoclonal antibodies specific  for mouse DC 
and IA  b'd antigens, respectively. The latter also binds to Swiss mouse cells. Both antibodies were 
purified by M. Witmer, The Rockefeller University, by diethylaminoethyl cellulose fractiona- 
tion of ascites. 
Primary cells.  Mice were killed in chloroform vapor or by cervical dislocation. Spleen cell 
suspensions were prepared by teasing with fine forceps  and pressing through a stainless steel 
mesh in RPMI 1640 (Gibco Laboratories, Grand Island Biological Co., Grand Island, NY). For 
unfractionated spleen  cells,  the  suspension was  treated  with  ammonium chloride  (0.88%: 
Mallinckrodt Inc., Science Products, Div., St. Louis, MO) to lyse erythrocytes. Spleen adherent 
cells, representing 1-2% of the total were obtained by culture in medium (see below)  on 100- 
mm petri dishes (3002; Falcon Labware, Div. of Becton, Dickinson & Co., Oxnard, CA) for 2- 
3 h  at  37°C. Nonadherent cells were then removed by rigorous washing; the adherent cells 
remaining consisted primarily of DC and macrophages in a ratio of ~ 1:3 (11). After overnight 
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culture the cells were harvested by gently pipetting over the tissue culture surface.  Enriched 
populations of DC were derived from low density adherent cells that consist predominantly of 
DC and macrophages.  After overnight culture, macrophages were depleted by readherence to 
60-mm petri dishes (3002;  Falcon Labware). 
T  lymphocytes  (>90%  Thy-1  positive)  were obtained  from  mixed spleen  and  mesenteric 
lymph node cell suspensions passed over nylon wool columns as described  (12). 
Medium for cell culture was RPMI  1640 supplemented with 2.5-10% heat-inactivated fetal 
bovine  serum  (KC  Biologicals Inc.,  Lenexa,  KS),  2-mercaptoethanol  (5  X  10  -5  M;  Sigma 
Chemical Co., St. Louis, MO), gentamycin sulphate  (20/~g/ml;  Schering Corp., Kenilworth, 
N J) and, for experiments in Table II, indomethacin (1/~g/ml; Sigma Chemical Co.). Cells were 
irradiated with  1,500  rad  from a  laTCs source  (Gamma Cell  1000;  Atomic Energy of Canada 
Ltd., Ottawa, Canada). 
Oxidative Mitogenesis Assay.  T  cell mitogenesis  was  induced  by  modification  of cells with 
periodate (13).  In one experiment  (see Fig.  1) stimulators and/or responders were treated, but 
in all others only responder T  cells were modified. T  lymphocytes were washed twice in ice-cold 
phosphate-buffered saline with calcium and magnesium (Gibco Laboratories) and resuspended 
in  the  same  to  2  ×  10V/ml.  An  equal  volume  of a  freshly  prepared  solution  of sodium 
m-periodate (Sigma Chemical Co.) at 0.5 mg/ml was added to the cells and incubated on ice 
for  15  min.  Control cells were treated with buffer alone.  The cells were centrifuged, without 
further dilution, at 300 g for 10 min and washed once in medium (2.5% serum)  before use. 
Graded numbers of irradiated stimulators were added to 4-5 ×  105 periodate-treated T  cells 
in a  total volume of 200 #1 in flat-bottomed microtiter plates  (3596;  Costar,  Data  Packaging, 
Cambridge,  MA). At 24-27  h, 0.5/~Ci/well of [3H]thymidine  (Schwarz/Mann  Div., Becton, 
Dickinson  & Co., Orangeburg,  NY)  was  added  and  cells were harvested  14-18  h  later on a 
multisample harvester. Kinetic studies (not shown) demonstrated that irrespective of stimulator 
dose, the bulk of DNA synthesis occurred from ~24 h onwards. Unless otherwise stated, results 
are given as the means of triplicate cultures;  standard  deviations were generally <15% of the 
mean. 
Primary Mixed Leukocyte Reaction.  Graded doses of irradiated unfractionated spleen or spleen 
adherent  cells were used  to stimulate proliferation of allogeneic T  lymphocytes in microtiter 
wells as described (11). 
Cytotoxic Elimination of Accessory Cells in Oxidative Mitogenesis.  Accessory cells were eliminated 
by treatment with monoclonal anti-Ia or anti-DC antibody and complement, in two different 
types of experiment. Medium for treatment contained 2.5% serum throughout. 
TREATMENT  OF  STIMULATORS  BEFORE  ADDITION  TO  T  CELLS  (SEE  TABLES  I,  II).  DC  were 
eliminated from fresh spleen adherent cells by treatment with antibody and complement during 
the adherence step  as described  (11).  Cultured  adherent  and unfractionated  spleen cells were 
resuspended  at 5-10 X  106/ml. They were incubated on ice with an equal volume of 33D1  or 
B21-2 antibody for 5-45 min at final, saturating concentrations of 10/~g/ml. Another volume 
of  complement  was  added  and  the  mixture  was  incubated  at  37°C  for  45-55  min.  The 
complement  source was rabbit  serum  screened for low background  toxicity, lyophilized, and 
stored at  -70°C  before use at  a  final dilution of 1:16.  After treatment  the cells were washed 
two to three times in ice-cold RPMI,  irradiated,  and  used as stimulators  for T  cell oxidative 
mitogenesis. 
TREATMENT  OF MIXED  POPULATIONS TO  EXAMINE DC-MEDIATED  T  CELL  ACTIVATION  (SEE  TABLES 
nI-v AND FinS. 2, 3).  Unirradiated DC were mixed with periodate-modified T  cells at ratios of 
1:100 to  1:30 as indicated. The mixture was either treated  immediately (t =  0) or distributed 
into 16-mm wells (3524; Costar) at  107/well in 1 ml of medium. At subsequent times, cells were 
harvested and the culture supernatant  was saved. Treatment with antibody and complement 
was as described above except that  the initial cell density was  10-12  ×  107/ml and  the cells 
were  not  irradiated.  After washing,  the  mixture  was  distributed  into  microculture  plates  at 
2-5 ×  105/well and 200 ~l total volume. The cultures were maintained in fresh medium, culture 
supernatant at 50%, crude rat IL-2 at 2.5-5%, purified mouse IL-2 at ~ 10  -9 M, or supplemented 
with DC at  1 ×  104/well. 
Interleukin Assays.  Two assays  (modifications of those in refs.  14 and  15, respectively) were 
used to test for the presence of interleukins: AUSTYN ET AL.  1103 
THYMOCYTE ~aITOCENESIS.  C3H/HeJ  thymocytes were  plated at  4-5  ×  105/well  in  flat- 
bottomed microtiter wells in a  total volume of 100/~1. Medium contained 2.5% serum, 0.8 #g/ 
ml phytohemagglutinin (Burroughs Welleome, Greenville, NC), a concentration determined to 
be suboptimal  to  induce  mitogenesis alone, and  5  ×  10  -5  M  2-mercaptoethanol, which  is 
essential for optimal responses to IL-1. Proliferation was assessed in a  14-18 h  [SH]thymidine 
pulse from day 2-3. 
PROLIFERATION OF AN 1L-2-DEPENDENT CELL LINE,  A cytotoxic T  lymphocyte line (CTLL) 
was used which proliferates in response to IL-2 but not to IL-1 (16). Two clones, CTLL-A2 and 
CTLL-A11, were used interchangeably. The line was maintained in minimal essential medium, 
Eagle (Gibco Laboratories) supplemented with 10% serum, 5 X  10  -5 M  2-mercaptoethanol, 5 
/,tg/ml  glutamine,  minimal essential medium  amino  acids  (Gibco Laboratories), and  4-5% 
polyclone (Collaborative Research Inc., Lexington, MA) as a source of IL-2. It was passaged 
after harvesting with 0.5%  EDTA (Mallinckrodt Inc.). On the day of assay, growth medium 
was replaced with IL-2-free medium at least twice over 4-5 h. After harvesting and washing to 
remove EDTA, cells were plated at 5-10 X  10S/well in flat-bottomed wells. Serial dilutions of 
sample  were  added  to  a  total  volume  of  100  /~1.  Proliferation  was  assessed  in  a 
[SH]thymidine pulse from day 1-2. 
IL-2.  IL-2  was  obtained  from  three  sources.  Supernatants  from  oxidative mitogenesis 
cultures that  were found  to contain  IL-2 (see Results)  were stored at  --20°C  before use. A 
standard source of crude rat IL-2 was prepared and generously provided by W. van Voorhis, 
The Rockefeller University. This was derived from Sephadex G 150 fractionation of a serum- 
free, concanavalin A (Con A)-stimulated spleen cell supernatant; fractions in the 14,000-28,000 
mol wt  range, which  supported proliferation of Con  A  blasts, were pooled. Purified mouse 
IL-2 was prepared as described (I7). Activity migrated as a single band of 23,000 tool wt by 
polyacrylamide gel  electrophoresis and  a  single  peak  of isoelectric point  (pI)  4.0-4.1  by 
isoelectric focusing. The concentration of IL-2 used in studies on T cell activation was saturating 
in the CTLL assay. 
Results 
The DC is the Critical Accessory Cell for T Lymphocyte Proliferation in Oxidative Mitogene- 
sis.  To  study  the  mechanism  of action of DC,  we chose a  polyclonal mitogenesis 
system  in  which  T  cells proliferate after  treatment  with  sodium  periodate.  Initial 
studies  confirmed  the  work  of  Klinkert  et  al.  (4)  showing  that  DC  were  potent 
stimulators of oxidative mitogenesis (Fig.  1).  Periodate treatment of DC, T  cells, or 
both, lead to large T  cell proliferative responses that were  10-100 times greater than 
those of unmodified  cells. Irradiated  (1,500  rad)  and  unirradiated  DC  had  similar 
effects (not shown). On  a  per cell basis, enriched DC  (>90% pure) were at least  100 
times more active as accessory cells than unfractionated spleen cells, which contained 
<1% DC  (Fig.  1). 
To document the contribution of DC further, selective depletion experiments were 
performed using the specific anti-DC  monoclonal  antibody,  33D1.  Treatment  with 
33D1  and complement  removed 90%  or more of the T  cell stimulatory capacity of 
spleen adherent cells. These were tested immediately after isolation from the animal 
(Table I) or following overnight culture  (Table II). Anti-DC antibody and comple- 
ment  also removed  50-75%  of the stimulatory capacity of freshly prepared, unfrac- 
tionated spleen cells (Table II). The effects of 33D1  and complement were similar to 
those produced by specific anti-Ia antibody and complement (e.g., Table I, experiment 
2). Selective elimination of DC had similar effects on accessory function in oxidative 
mitogenesis and the primary mixed leukocyte reaction (MLR)  (Table II and ref.  11). 
Treatment  with  33D1  antibody alone, antibody, and  heat-inactivated complement 
(Tables I and II), or the continuous presence of antibody at 20/tg/ml (not shown) did 1104  TWO  STAGES  IN  DENDRITIC  CELL-INITIATED  T  PROLIFERATION 
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F1o.  l.  The  relative potency of DC compared  with unfractionated  spleen  cells as stimulators in 
oxidative mitogenesis.  Graded  numbers  of irradiated  Swiss mouse  DC  (  )  or  unfractionated 
spleen cells (- -  -) were added to 5  ×  l0  s T  cells in medium containing 5% serum, and proliferation 
was assessed.  Periodation was carried out before mixing, on both  stimulators and  responders  (O), 
responders only (~), stimulators only (Lx), or neither (×). 
not  alter  DC  function.  We  conclude  that  the  DC  is  the  critical  cell  required  to 
stimulate the proliferation of periodate-modified T  cells. 
Release  of Interleukins  during  Oxidative  Mitogenesis.  Interleukins,  notably IL-1  (lym- 
phocyte-activating factor, reviewed in  19) and IL-2 (T cell growth factor, reviewed in 
6-8),  can act as effector molecules for lymphocyte mitogenesis.  We therefore tested 
supernatants  from DC, T  cells, and DC-T cell co-cultures for interleukin  activity in 
two standard  bioassays. These were costimulation with phytohemagglutinin  of thy- 
mocyte mitogenesis, which  detects both IL-1 and  IL-2 (18),  and proliferation of an 
IL-2-dependent T  cell line, which detects only IL-2. 
The  supernatants  from  DC-T  cell  co-cultures  were  active  in  stimulating  both 
thymocyte mitogenesis and proliferation of the IL-2-dependent CTLL line  (Fig.  2). 
The interleukin activity in both bioassays was parallel. Interleukins were not detected 
in cultures of DC alone (up to  106/ml;  not shown).  Low levels of IL-2 activity were 
found in supernatants of T  cells cultured in the absence of DC, but these were always 
<10%  of that  of the  DC-T  cell  mixture.  During  oxidative  mitogenesis  (DC  plus 
periodate-modified T  cells), IL-2 activity was detected at the first time point studied 
(3 h), peaked by 20 h, and then fell rapidly in the 2nd d  of culture  (Fig. 2).  Similar 
kinetics  were  observed  in  four  consecutive  experiments.  If the  T  cells  were  not 
periodate-modified  (the  syngeneic MLR),  the  rate  of IL-2 release  was  slower,  but 
proceeded continuously over 4 d  in culture  (Fig. 2).  We conclude that DC stimulate 
the release of IL-2 during  DC-T cell co-culture.  The bioassays did not  allow  us  to 
determine whether IL-1 was also present. 
The Dendritic Cell Induces Periodate-Modified  T Cells to Respond to Soluble Factors Released 
into the  Culture  Medium.  Although  the  culture  medium  from oxidative  mitogenesis AUSTYN ET AL. 
TABLE  I 
Selective Ehmination of DC Reduces the Accessory Activity of Freshly Prepared 
Spleen Adherent Cells 
~'.n  i  _xver -  Strain  Treatment  Proliferation 
ment 
cprtl 
1  C × B6 FI  O  66,123 
O/C  *  53,199 
33D1  62,177 
33D t/C*  7,802 
2  C × B6 F1  O/heat  56,484 
33D 1/heat  52,856 
B21-2/heat  51,140 
O/C*  44,024 
33D l/C*  6,339 
B21-2/C*  1,486 
3  D2 × C F1  O/C*  47,067 
33D l/C*  4,535 
4  D2 × C F1  O/C*  33,226 
33D l/C*  1,288 
5  B  10.TL  O/C*  52,206 
33D 1/C*  4,059 
Freshly harvested, unfractionated spleen cells from the mouse strains indicated 
were irradiated  and cultured  at  3-4 ×  l0  s per  16-mm well in the presence 
(33D1; B21-2) or absence (O) of antibody and complement (C*, fresh; heat, 
heated at 56°C for 30 min; no symbol, medium only at this stage), as indicated 
for  60  rain  at  37°C. Nonadherent  cells were removed  by  washing, thus 
providing adherent spleen cells at doses estimated to be 5-10 ×  104 per well. 
20-30% of the adherent cells were DC. Periodate-modified T ceils were added 
as responders in 2.5% serum. Proliferation was measured on the second day of 
culture and the responses of T cells only were subtracted. 
1105 
cultures contained IL-2 activity, these supernatants  alone would not induce prolifer- 
ation of periodate-modified T  cells  (see below for examples).  We therefore designed 
experiments to test if T  cells became responsive to growth factors after co-culture with 
DC. DC and T  cells were cultured for varying lengths of time (0-20  h),  after which 
the  DC were killed with anti-DC or anti-Ia monoclonal antibody and  complement. 
Removal of DC  with  either of the  antibodies  reduced  the  subsequent  proliferative 
response of the treated cells, recultured in fresh medium. However, anti-Ia was more 
effective than anti-DC at later times (10-20 h, Table III). Proliferation of DC-depleted 
cultures  was  restored  by  adding  back  small  numbers  (1-3%)  of DC,  showing  that 
treatment with antibody and complement had not altered the T  cells (Table III). 
The  striking  finding was  that  T  cells  that  had  been  cultured  with  DC  became 
progressively responsive  to  soluble  factors  (Table  III  and  Fig.  3).  The  latter  were 
obtained  from  the  DC-T  cell-conditioned medium,  or  from  a  standard  interleukin 
source (crude rat IL-2 derived from Con A-stimulated rat spleen cells). Responsiveness 
to soluble factors  increased progressively with time (Table III and  Fig. 3),  and with 
increasing numbers of DC (Fig. 3), but T  cells cultured in the absence of DC were not 
responsive  (Fig.  3).  We  conclude  that  at  least  two  events  occur  in  the  1st  d  of an 
oxidative mitogenesis culture: exposure to DC causes the T  cells to become responsive 1 106  TWO  STAGES  IN  DENDRITIC  CELL-INITIATED  T  PROLIFERATION 
TABLE  II 
Selective Elimination of DC Reduces Accessory Cell Function of Cultured Spleen Adherent Cells and Fresh 
Unfractionated Spleen Cells 
Proliferative response of 5 ×  105 responders to stim-  Stimulators  Treatment  ulators at a dose of (×10  -3) 
Oxidative mitogenesis 
Spleen adherent cells 
Unfractionated spleen cells 
Allogeneic MLR 
Spleen adherent cells 
Unfractionated spleen cells 
cpm 
24  12  6  3 
O  49,010  28,710  15,050  7,150 
O/C*  40,765  23,752  18,238  7,505 
33D1  38,689  30,324  18,887  8,903 
33D1/C*  8,765  4,685  1,782  664 
320  160  80  40 
O  11,147  9,269  5,220  3,186 
O/C*  19,461  10,280  5,871  3,657 
33D1  25,046  13,864  7,728  3,796 
33D1/C*  8,071  3,194  1,687  713 
24  12  6  3 
O  87,524  61,697  44,347  24,724 
O/C*  76,766  60,498  45,453  19,375 
33D 1  75,995  53,513  31,249  12,686 
33D 1/C *  2,707  1,150  790  523 
320  160  80  40 
O  60,739  30,880  12,763  2,079 
O/C*  37,464  20,264  6,211  2,052 
33D 1  63,943  41,976  17,254  6,544 
33D1/C*  14,874  3,064  655  355 
C ×  B6 Fa stimulator cells were treated in the presence or absence of antibody and complement (designated 
as in Table I). The stimulators were irradiated and added to C × B6 F1 periodate-treated T cells (oxidative 
mitogenesis) or untreated BALB/c T cells (allogeneic MLR). Oxidative mitogenesis was assayed from day 
1-2: control responses with unmodified T cells were <700 cpm. The allogeneic MLR was assayed from day 
4-5:  syngeneic MLR responses were <2,250  cpm.  Cultures were a  2.5% serum. The proportion of DC, 
macrophages and Ia-bearing (Ia  +)  cells  was  determined by indirect immunofluorescence using specific 
monoclonal antibodies 33D1,  F4/80  (38),  and B21-2,  respectively.  Spleen adherent cells were the same 
population characterized previously (ref. 11). They contained a two- to threefold excess of Ia  ÷ macrophages 
to Ia  + DC.  Unfractionated spleen cells contained <1% DC, 3% macrophages, and 65% Ia  + cells. Killing 
with 33D1  and complement was ~25% in spleen adherent cells but was not detectable in unfractionated 
spleen cells. 
to  soluble  factors,  and  DC  induce  release  of the  required  factors  into  the  culture 
medium. 
Purified  IL-2  Drives  Proliferation  of Responsive  T  Cells.  To  pinpoint  the  molecule 
responsible for mitogenesis, we tested a  purified preparation  of mouse IL-2, prepared 
as  previously  described  from  the supernatants  of Con  A-stimulated  spleen  cells  (17). 
This IL-2 had  an apparent  molecular weight of 23,000,  migrated  as a  single band  on 
isoelectric focusing with a  pI of 4.0-4.1,  and  saturated  the IL-2 bioassay at  10  -9 M. 
After  varying  times  of  DC-T  cell  co-culture,  DC  were  removed  with  anti-Ia 
antibody  and  complement.  Then  the T  cells  were  recultured  in  fresh  medium,  the 
original DC-T  cell culture supernatant,  or purified IL-2  (Table IV). The  purified IL- AUSTYN  ET  AL.  1107 
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Fro.  2.  Kinetics of interleukin production  during De-induced T  lymphocyte proliferation.  The 
responses examined were oxidative mitogenesis (O)  and the syngeneic MLR ([3). Swiss mouse DC 
were mixed with periodate-modified (O, O) or untreated ~lg,  El) T  cells at a ratio of 1:50 in medium 
containing 2.5% serum. Closed symbols indicate T  cells cultured in the absence of DC. The mixture 
was distributed  at  8  x  10  ~ per well  in  I  ml into  16-mm wells. Cells from individual wells were 
harvested at the times shown. The supernatant was assayed for interleukin activity by determining 
the induction of thymocyte mitogenesis (left)  and proliferation  of an IL-2-dependent T  cell line 
(right). 
2,  tested  at  10  -9 M,  had  similar activity to  the DC-T cell conditioned  medium  in 
promoting proliferation (Table IV), which was likewise restored by crude rat IL-2 or 
small numbers of DC (not shown). Fresh T  cells, or T  cells cultured in the absence of 
DC, did not respond to IL-2. Unmodified T  cells (1  d  syngeneic MLR) also became 
responsive to IL-2 when cultured with DC, but the responsiveness was <20% of that 
seen in oxidative mitogenesis (Table IV, experiment 2). We conclude that IL-2 itself 
mediates the proliferation of DC-stimulated T  cells. 
IL-2 and  Viable DC Do  Not Act  Synergistically.  IL-2  replaces  DC  after an  initial 
period  (6-20 h)  of DC-T cell co-culture. We asked whether IL-2 could enhance the 
function of live DC when both were present continuously from the onset of culture. 
Purified IL-2, used at a concentration that saturated the IL-2 bioassay, and mediated 
the  proliferation  of  activated  T  cells,  did  not  enhance  oxidative  mitogenesis 
induced by a wide range of DC doses (Table V). This is in agreement with the results 
of experiments in Table IV where purified IL-2 did not enhance proliferation of cells 
treated with complement alone. We conclude that IL-2 mediates proliferation of DC- 
activated T  cells but does not act synergistically with live DC in the activation step. 
As  a  corollary,  the  restoration  of proliferation  in  activated T  cells  is not  due  to  a 
synergistic effect of IL-2 with very small numbers of residual DC. 
Discussion 
The  DC  is  the  Principal  AccessoTy Cell  in  Oxidative Mitogenesis.  Novogrodsky  and 
Katchalski (20) discovered that lymphocytes proliferated after treatment with sodium 
periodate,  or with  neuraminidase  and  galactose oxidase.  Greineder  and  Rosenthal 
(21)  noted that oxidative mitogenesis in the guinea pig, like other T  cell responses, 
required accessory cells. Either the accessory cells, assumed to be macrophages, or the 
T  cells needed to be oxidized for mitogenesis to ensue. Klinkert et al. (4) demonstrated 1108  TWO  STAGES  IN  DENDRITIC  CELL-INITIATED  T  PROLIFERATION 
TABLE  IliA 
DC Progressively Activate  T  Cells to Respond to Soluble Factors Released into 
the Culture Supernatant 
Co-cuhure of DC 
with periodate T  cells 
Proliferative response of 3 X  l0  s treated cells 
after reconstitution with: 
Time  Treatment  Medium  DC  Superna-  Crude rat 
tam  IL-2 
h  cpm 
0  O  32,107  46,864  30,598 
O/C*  18,978  69,200  22,239 
33D1/C*  407  48,663  1,761 
B21-2/C*  46  37,835  393 
10 
20 
O  28,983  48,633  28,420  38,194 
O/C*  24,365  68,779  24,114  31,159 
33D1/C*  698  45,334  1,706  7,669 
B21-2/C*  106  33,683  349  3,424 
0  46,800  66,809  57,801  55,107 
O/C*  40,t03  79,038  58,125  62,245 
33D1/C*  4,117  73,804  28,903  37,864 
B21-2/C*  340  64,094  12,879  23,041 
O  68,411  80,622  63,337  81,827 
O/C*  57,165  94,790  76,165  78,137 
33D1/C*  15,128  77,545  53,536  60,292 
B21-2/C*  1,487  83,974  47,032  58,895 
O  59,939  113,962  98,781  92,952 
O/C*  50,422  84,596  91,731  66,807 
33D1/C*  25,493  56,655  70,082  46,724 
B21-2/C*  16,858  63,742  90,504  61,654 
At successive times, mixtures of Swiss mouse DC and  periodate-modified T 
cells  at  a  ratio  of  1:100  were  treated  with  antibody  and  complement  as 
indicated. They were then recultured in fresh medium containing 2.5% serum, 
fresh DC at 3% of the total, a saturating (2.5% vol/vol) concentration of crude 
rat  IL-2  (used to obtain an estimate of the maximum response attainable at 
each time after removal of DC), or 50% of the culture supernatant collected at 
each time point. This contained progressively increased concentrations of IL- 
2 in a  CTLL assay as shown below.  Rat  IL-2 was diluted to a  10% starting 
concentration and the background was 1,122  cpm. 
IIIB 
Time of su- 
pernatant col- 
lection 
Proliferative response of CTLL cells with supernatant 
at concentration of: 
50%  25%  12%  6% 
a  ~pm 
3  6,424  3,708  2,673  1,536 
6  39,283  28,340  17,739  9,668 
10  47,859  40,881  33,536  18,831 
20  42,128  38,433  38,799  26,470 
rat IL-2  48,244  44,058  37,103  ND* 
* Not determined. 0 
1:100 
1:30 
RATIO 
DC:T 
0 
1 : 100 
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FIG. 3.  DC  activate T  lymphocytes  to become  responsive  to soluble factors. The  experiment 
illustrated  is similar to that in Table Ill,  except that I  l- and 17-h points were examined, two ratios 
of DC:T were used, and the medium contained 10% serum. Briefly, at the times indicated, the cells 
were  treated  with  B21-2  and  complement  (aIa/C)  or  complement  alone  (O/C).  They  were 
recultured in  fresh  medium  (m),  or  50% supernatant  (s)  from  the original 11-  or  17-h cultures. 
Cultures in medium with 2.5%  serum were also tested with qualitatively similar results. However 
the degree of proliferation was reduced when the cells were cultured in 2.5% serum before treatment 
(the activation step) but the serum concentration had no effect after activation (results not shown). 
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that  enriched populations  of DC  were  active  accessory cells  in  the  rat,  and  that 
macrophages and lymphocytes were in fact weak or inactive. Philips et al.  (5)  and 
van  Voorhis  et  al.  (22)  found  similarly  in  mouse  and  humans,  respectively.  We 
confirmed in  this paper that  highly enriched  (>90% pure)  mouse spleen DC were 
potent stimulators of oxidative mitogenesis (Fig. 1). Furthermore, selective elimination 
of DC  with  the  specific  33D1  monoclonal  antibody  and  complement,  markedly 
reduced  the  accessory function of unfractionated spleen  and  spleen adherent  cells 
(Tables I  and  II). This specific, negative selection approach, which was applied to 
fresh  or  cultured  cell  suspensions,  extends  previous  evidence  that  the  DC  is  the 
principal  leukocyte mediating  oxidative mitogenesis.  33D1  is  the  first  cell-specific 
antibody to so strikingly diminish accessory function. 
Oxidative Mitogenesis as a  Model for a  De-mediated  T  Cell Response.  Oxidative mito- 
genesis is a  particularly useful model to study the mechanism of action of De. First 
the  response  is  large,  comparable  in  magnitude  to  lectin-stimulated  proliferation. 
Second, unlike lectin models, it is easy to make T  cells accessory cell dependent:  a 
single passage of spleen or lymph node cells over nylon wool reproducibly yields T 
cells that  are dependent upon small numbers of De.  Third, responses are rapid so 
that  within  2  d  it  is possible  to monitor early events in  moving the T  cell from a 
resting or unprimed state into its first cell cycle. Responses to specific antigens, such 
as alloantigens in the primary MLR, or to soluble protein antigens, require long assay 
times  and/or  primed  T  cells.  Fourth,  oxidative  mitogenesis  is  blocked  by  anti-Ia 
antibodies  (23 and J.  M.  Austyn, unpublished observations) administered continu- 1110  TWO  STAGES  IN  DENDRITIC  CELL-INITIATED  T  PROLIFERATION 
TABLE  IV 
Purified IL-2 Mediates the Proliferation of T Lymphocytes after Their Activation by DC 
Experiment/Assay 
Co-culture  Proliferative  response of 3 ×  l0  s treated 
cells recultured in: 
~  n 
Time  Treatment  Medium  ouverna-  Pure IL-2 
tant 
Experiment 1 
Oxidative mitogenesis 
h  cpm 
0  O/C*  59,452  53,678  47,556 
B21-2/C*  65  1,097  507 
6  O/C*  129,158  136,812  105,801 
B21-2/C *  719  18,395  12,450 
10  O/C*  81,667  84,366  82,395 
B21-2/C*  3,426  46,407  29,968 
20  O/C*  136,451  136,715  133,023 
B21-2/C*  46,446  127,608  102,386 
Experiment 2 
Oxidative mitogenesis 
1-d syngeneic MLR 
Periodate T cells only 
0  O/C*  99,707  83,846  79,049 
B21-2/C*  86  232  617 
15  O/C*  120,906  154,594  125,406 
B21-2/C*  32,982  116,633  112,995 
0  O/C*  3,463  3,659  3,139 
B21-2  67  577  289 
15  O/C*  17,308  17,067  16,975 
B21-2/C*  4,832  12,521  11,751 
0  O/C*  141  145  105 
B21-2/C*  83  7I 1  I29 
15  O/C*  905  3,618  1,500 
B21-2/C*  149  871  528 
As in Table III and Fig. 3, cells were cultured for varying lengths of time before treatment with or without 
anti-la antibody and complement. They were then recultured in either fresh medium containing 2.5% or 
10% serum (experiments I and 2, respectively) or the same supplemented with a saturating concentration 
of purified mouse IL-2, or DC-T cell culture supernatant. In experiment 1, the supernatant added at t = 
0 was from a 20-h culture of DC and periodate-modified  T cells; those at later times were from the original 
cultures.  In experiment 2, the supernatant used throughout was from a similar 18-h oxidative mitogenesis 
culture. Addition of small numbers of purified DC restored the proliferation of B21-2/C*-treated cultures 
and the effect of crude rat IL-2 was similar to that of pure mouse IL-2  (results not shown). In experiment 
2, where pure IL-2 was added at 15 h, T cells were exposed to IL-2 for i2 h before the thyrnidine pulse. In 
other experiments, incubation was continued for 28 h  before pulsing.  The results  were similar to those 
shown here. Cultures of DC with unmodified T cells are termed 1-d syngeneic MLR. 
ously, indicating that  polyclonal activation with periodate requires major histocom- 
patibility  complex  (MHC)  antigens  as  do  many  antigen-induced  proliferative  re- 
sponses. 
The precise mechanism whereby periodate enhances T  cell mitogenesis is currently 
unknown.  Possibly  periodate  simply  enhances  the  so-called  syngeneic  MLR  that 
occurs when DC  and T  cells are mixed (24).  All the events that occur when DC  are 
added  to  periodate-modified T  cells  are  quantitatively  increased relative  to  events 
occurring in the syngeneic MLR  (Table IV, experiment 2;  and Fig. 2). 
Two Stages in T  Cell Mitogenesis.  Experiments with periodate-modified T  cells have AUSTYN  ET  AL. 
TABLE V 
Purified IL-2 Does Not Enhance the Effect of DC m Oxidative 
Number of DC 
Proliferative response of 4 ×  l0  s 
cells in 
Mitogenesis 
periodate T 
Medium  IL-2 
cp,n 
2 ×  104  90,895  82,803 
I X 104  46,045  46,138 
5 ×  10  a  27,788  23,058 
2.5 ×  10  a  10,133  9,803 
1.2 ×  t0  s  3,405  4,485 
6 ×  l02  1,747  2,328 
3 ×  102  805  1,480 
None  350  1,068 
Proliferative response of 4 X 105 
unmodified T cells 
2 X 104  3,573  6,393 
1 ×  104  2,007  2,417 
5 ×  10  a  837  1,760 
None  88  538 
Graded numbers  of irradiated Swiss mouse  DC  were  added to  periodate- 
treated or unmodified  T  cells. The  proliferative  response was  assessed in 
medium  containing 10% serum or the same supplemented  with a saturating 
concentration  of pure mouse IL-2 (as used for experiments in Table IV). 
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provided a  two-stage model of DC-initiated mitogenesis. In the first stage, viable DC 
induce both the release of IL-2 and T  lymphocyte responsiveness to this factor. In the 
second, which does not require viable DC, T  cells proliferate in response to the IL-2 
that is generated in the culture medium. 
Release of IL-2 activity into the culture medium, and acquisition of responsiveness 
to  IL-2, occurred  over a  similar time course  (compare Fig.  2  and  Table III). Both 
events were  induced by DC  and were  required for mitogenesis. It is likely that  the 
IL-2  was  derived  from  T  cells,  rather  than  DC,  since  T  cell  lines  are  the  only 
homogeneous populations known to release this factor (e.g., 25, 26). We do not know 
if the subpopulation of T  cells that responds to IL-2 is different from, or overlaps, that 
which releases IL-2. IL-2 itself, in the form of supernatant from DC-T cell cocultures, 
or as crude or pure preparations from Con A-stimulated spleen cells, had no effect on 
T  cells that were not first activated by DC. 
Previous work  indicated that  T  cell growth  factor,  or IL-2, does  not  trigger the 
growth of resting T  cells (27, 28). Rather, IL-2 acts in conjunction with other signals, 
or these cells must  first be "activated" to respond to IL-2, a  process which includes 
expression  of functional  receptors  (28-30).  The  distinctive  findings  in  this  paper, 
which were verified with a highly purified preparation oflL-2, were: (a) responsiveness 
to IL-2 was acquired progressively (6-20 h) during exposure to small numbers of DC, 
before the onset of the first cell cycle;  (b) sufficient IL-2 was generated in DC-T cell 
co-cultures to account for the proliferative response; and (c) IL-2 seems to be the only 
mediator required by the activated T  cell to ensure its first cell division. 
The above conclusions were derived from experiments (Tables III and IV, Fig. 3) 1112  TWO STAGES IN DENDRITIC CELL-INITIATED T  PROLIFERATION 
in which  T  cells were cultured  with  DC for varying lengths of time.  The DC were 
then  killed  with  anti-Ia  or  anti-DC  antibody  and  complement.  Such  treatment 
drastically inhibited  subsequent proliferation in  fresh medium. The greater efficacy 
of anti-Ia antibody, compared with 33D1 at later times was presumably due to more 
efficient killing of DC by the former: the 33D1  antigen may be modulated, become 
inaccessible, or other factors could be involved. Anti-Ia also became less efficient at 
the later times studied (15-20 h). Possibly the T cells become committed to replication 
in the absence of DC and exogenous IL-2. Finally, in these experiments, mitogenesis 
was triggered by soluble factors, including a highly purified preparation of IL-2. The 
latter does not seem to enhance the function of DC (Tables III, IV, and V, and Fig. 
3). Rather, the DC triggers the T  cell to release and to respond to IL-2: the number 
of  DC  in  the  culture  tightly  controls  the  extent  of  lymphocyte  activation,  and 
endogenous IL-2 release and action. 
It is important  to  relate oxidative mitogenesis to other T  lymphocyte responses. 
Primed cytolytic T  cells may be stimulated by antigen acting in concert with soluble 
factors, and may not require interaction with intact accessory cells (31).  Some lectins 
and  other  stimuli  (27,  32-35)  induce  IL-2  responsiveness,  again  in  the  apparent 
absence of accessory cells.  For example, Larsson and co-workers (34,  35)  studied  T 
cells depleted of Ia-bearing cells. Culture with Con A altered the T  cell in a few hours 
so  that  it  then  responded  to exogenous  factors  from Con  A-stimulated  spleen  cell 
supernatants. In contrast, DC-depleted, periodate-modified T  lymphocytes proliferate 
little  if  at  all  in  the  presence  of  IL-2.  Ia-bearing  cells  are  required  for  Con  A 
mitogenesis (36, 37), and it has been suggested that such cells function solely to induce 
IL-2 release.  In oxidative mitogenesis,  the  Ia-bearing DC  itself alters  the T  cell  to 
respond to IL-2, in addition to inducing IL-2 release. Conceivably Con A mimics the 
action of DC  in inducing T  cell responsiveness.  Because the  first stage in oxidative 
mitogenesis demands cellular interaction with live DC, and because sufficient IL-2 is 
produced to drive the second, proliferative stage, this model may approximate more 
closely  to  the  physiological  triggering  of T  cells.  We  are  currently  examining  the 
extension of this model to antigen-driven T  cell responses. 
Summary 
T  cells  oxidized  with  sodium  periodate  proliferate  polyclonally  in  response  to 
accessory cells. We confirmed previous work showing that DC are potent stimulators 
of this response.  In addition,  the accessory function of unfractionated  mouse spleen 
and  spleen  adherent  cells  was  markedly  reduced  after  elimination  of DC  with  a 
specific monoclonal antibody and complement. Therefore oxidative mitogenesis was 
used as a  model to study the mechanism by which DC stimulate T  cell proliferative 
responses. 
A two-stage mechanism was identified. The first stage occurred during the first 20 
h  of culture, required  live DC,  and involved the progressive release of interleukin  2 
(IL-2) into the medium and acquisition of responsiveness to this growth factor. The 
second stage occurred between  20 and 40 h,  did not require live DC,  and involved 
DNA synthesis in response to IL-2. Similar events occurred during culture of DC with 
unmodified T  cells  (syngeneic MLR)  but  were quantitatively  reduced.  The experi- 
mental approach was to co-culture DC and T  cells for up to 20 h  and then kill the 
DC with specific antibody, or anti-Ia antibody, and complement. Subsequent prolif- AUSTYN ET AL.  1113 
eration  was  inhibited  if  the  T  cells  were  cultured  in  fresh  medium.  However, 
proliferation was restored when the lyrnphocytes were cultured in the original DC-T 
cell medium, or with a  crude or a  purified preparation of IL-2. IL-2 did not induce 
the proliferation of T  cells that had been cultured in the absence of DC, and did not 
synergize  with  viable  DC.  We  conclude  that  DC  induce  proliferation  by  tightly 
coordinating the release of, and responsiveness to, T  cell growth factor or IL-2. 
The authors are grateful to Dr. Zanvil Cohn for reviewing the manuscript. 
Received for publication  15 December 1983. 
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